Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice.
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice. Expert Opin Pharmacother. 2019 Jan 29;:1-12 Authors: Amodeo G, Cuomo A, Bolognesi S, Goracci A, Trusso MA, Piccinni A, Neal SM, Baldini I, Federico E, Taddeucci C, Fagiolini A Abstract INTRODUCTION: Binge eating disorder (BED) is the most common eating disorder and was newly recognized in 2013 in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). BED is frequently associated with obesity and the metabolic syndrome, as well as with other psychiatric diseases, such as mood (49%), anxiety (41%), and substance use (22%) disorders. BED is highly prevalent and carries a high burden of mental and physical illness and disability. However, BED is frequently under-recognized and under-treated. Areas covered: This paper reviews the main pharmacological treatments for BED and provides an expert opinion based on the available evidence and on the authors' clinical experience with patients affected by BED. Expert opinion: Several medications have proven to be effective for the treatment of BED, including Lisdexamfetamine (LDX), topiramate as well as anti-anxiety and antidepressant medications. To date, LDX is the only FDA approved medication for BED. Consequently, as a general rule, the use of an FDA approved medication should always be preferred. However, when in the presence of concomitant psychia...
Conclusions: Nutrition counseling was rarely documented in a large sample of electronic medical record (EMR) data from pediatric wellness visits in South Carolina-a state heavily burdened by childhood obesity. Children's BMIs were infrequently recorded, which may be a barrier to tracking BMI over time. Sociodemographic and geographic differences in nutrition counseling may exacerbate disparities in childhood obesity. PMID: 32960095 [PubMed - as supplied by publisher]
Publication date: November–December 2020Source: Heart &Lung, Volume 49, Issue 6Author(s): Linda Clements, Susan K. Frazier, Debra K. Moser, Terry A. Lennie, Misook L. Chung
Publication date: 1 January 2021Source: Personality and Individual Differences, Volume 168Author(s): Feizhong Zheng, Wenting Wu, Lijing Wang, Arlette J. Ngoubene-Atioky, Li Chen
Publication date: Available online 22 September 2020Source: International Journal of PsychophysiologyAuthor(s): Chiara Massullo, Giuseppe Alessio Carbone, Benedetto Farina, Angelo Panno, Cristina Capriotti, Marta Giacchini, Sérgio Machado, Henning Budde, Eric Murillo-Rodríguez, Claudio Imperatori
CONCLUSION: In a NHP ARS model, sargramostim administered starting at 48 h post-radiation was effective to improve survival, while beneficial hematological effects were observed with sargramostim initiated up to 120 h post exposure. PMID: 32960660 [PubMed - as supplied by publisher]
Abstract Even though bariatric surgery is one of the most effective treatment option of obesity, post-surgical weight loss is not always ensured, especially in the long term, when many patients experience weight regain. Bariatric procedures are largely based on surgeon's expertise and intra-operative decisions, while an integrated in-silico approach could support surgical activity. The effects of bariatric surgery on gastric distension, which activates the neural circuitry promoting satiety, can be considered one of the main factors in the operation success. This aspect can be investigated trough computational mod...
Publication date: Available online 22 September 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Morten AV. Lund, Anne H. Thostrup, Christine Frithioff-Bøjsøe, Ulrik Lausten-Thomsen, Paula L. Hedley, Oluf Pedersen, Michael Christiansen, Torben Hansen, Jens-Christian Holm
In 2019, before the pandemic hit, nearly 1 in 5 adults had depression and nearly 1 in 6 had anxiety, with dramatic increases seen in 2020.Medscape Medical News
Publication date: November 2020Source: Epilepsy &Behavior, Volume 112Author(s): Mehri Salari, Masoud Etemadifar, Koroush Gharagozli, Koorosh Etemad, Farzad Ashrafi, Helia Ashourizadeh
Publication date: November 2020Source: Epilepsy &Behavior, Volume 112Author(s): Daniel Delev, Karlijn Hakvoort, Alexander Grote, Georg Neuloh, Hans Clusmann, Marec von Lehe